Arcturus Therapeutics Holdings (ARCT) Net Income towards Common Stockholders (QoQ) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) Net Income towards Common Stockholders (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 165.13 Mn | -46.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.78% |
| Dec 31, 2025 | -116.13% |
| Sep 30, 2025 | -46.49% |
| Jun 30, 2025 | 34.78% |
| Mar 31, 2025 | 53.09% |
| Dec 31, 2024 | -334.67% |
| Sep 30, 2024 | 59.79% |
| Jun 30, 2024 | 35.99% |
| Mar 31, 2024 | -129.07% |
| Dec 31, 2023 | 27.86% |
| Sep 30, 2023 | 69.13% |
| Jun 30, 2023 | -203.58% |
| Mar 31, 2023 | -57.22% |
| Dec 31, 2022 | 436.42% |
| Sep 30, 2022 | -63.55% |
| Jun 30, 2022 | 57.94% |
| Mar 31, 2022 | -35.58% |
| Dec 31, 2021 | 38.29% |
| Sep 30, 2021 | 0.66% |
| Jun 30, 2021 | 6.74% |